Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Correlation Between Tarceva-Induced Rash and Efficacy in EGFR-mutated NSCLC
NCT01174563Phase 2Completed
- Sponsor
- Roche
- Start
- May 2011
- Primary completion
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Roche. Started May 2011; status: completed.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01174563.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01174563.